HomeCompareNPRRF vs PLD

NPRRF vs PLD: Dividend Comparison 2026

NPRRF yields 1.90% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.48M in total portfolio value
10 years
NPRRF
NPRRF
● Live price
1.90%
Share price
$9.96
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$214.67
Full NPRRF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — NPRRF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPRRFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPRRF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPRRF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPRRF
Annual income on $10K today (after 15% tax)
$161.38/yr
After 10yr DRIP, annual income (after tax)
$182.47/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,467,788.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPRRF + PLD for your $10,000?

NPRRF: 50%PLD: 50%
100% PLD50/50100% NPRRF
Portfolio after 10yr
$3.26M
Annual income
$2,628,325.43/yr
Blended yield
80.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

NPRRF
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPRRF buys
0
PLD buys
0
No recent congressional trades found for NPRRF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPRRFPLD
Forward yield1.90%3.18%
Annual dividend / share$0.19$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$22.5K$6.50M
Annual income after 10y$214.67$5,256,436.18
Total dividends collected$2.0K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NPRRF vs PLD ($10,000, DRIP)

YearNPRRF PortfolioNPRRF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,890$189.86$11,255$555.24$365.00PLD
2$11,845$193.23$13,062$1,018.59$1.2KPLD
3$12,871$196.43$15,903$1,926.67$3.0KPLD
4$13,971$199.48$20,839$3,823.32$6.9KPLD
5$15,152$202.37$30,464$8,166.08$15.3KPLD
6$16,418$205.11$52,054$19,457.30$35.6KPLD
7$17,774$207.70$109,886$54,188.93$92.1KPLD
8$19,229$210.16$304,030$186,451.18$284.8KPLD
9$20,787$212.48$1,166,125$840,813.32$1.15MPLD
10$22,457$214.67$6,504,190$5,256,436.18$6.48MPLD

NPRRF vs PLD: Complete Analysis 2026

NPRRFStock

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. The company's Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, syringes, and cartridges; glass tubes; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Full NPRRF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this NPRRF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPRRF vs SCHDNPRRF vs JEPINPRRF vs ONPRRF vs KONPRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.